Nichols, E., Steinmetz, J.D., Vollset, S.E., Fukutaki, K., Chalek, J., Abd-Allah, F., Abdoli, A., Abualhasan, A., Abu-Gharbieh, E., Akram, T.T., Al Hamad, H., Alahdab, F., Alanezi, F.M., Alipour, V., Almustanyir, S., Amu, H., Ansari, I., Arabloo, J., Ashraf, T., Bezabih, Y.M., et al. (2022) Estimation of the Global Prevalence of Dementia in 2019 and Forecasted Prevalence in 2050: An Analysis for the Global Burden of Disease Study 2019. The Lancet Public Health, 7, e105-e125.
https://doi.org/10.1016/S2468-2667(21)00249-8

has been cited by the following article:

• TITLE: Studying Alzheimer’s Disease Using Drosophila melanogaster as a Powerful Tool

  AUTHORS: Jacob Kasanin, Xingjun Wang, Wanting Jiao, Qiuyu Li, Bingwei Lu

  KEYWORDS: Drosophila, Alzheimer’s Disease, APP, C99, Aβ42, Tau

  JOURNAL NAME: Advances in Alzheimer's Disease, Vol.11 No.3, September 30, 2022

  ABSTRACT: Background: Alzheimer’s disease (AD) is an increasingly prevalent neurodegenerative disease characterized by protein aggregation in the form of amyloid plaques containing beta-amyloid peptides and neurofibrillary tangles containing hyperphosphorylated tau protein. The central molecular events underlying AD pathogenesis remain controversial and poorly defined. Drosophila melanogaster has emerged as an important genetic resource for studying the pathology of AD. Many AD models have been created using Drosophila, taking advantage of its short generation times, sophisticated genetic tools, and abundance of homologs to human genes. Purpose: This review summarizes different models for studying AD in Drosophila melanogaster, including the full-length APP, C99, Aβ42 and Tau models, explaining how the models were built and what we have learned from them. Conclusion: Four main AD Drosophila models are introduced in this review, which can serve as a future method to investigate genes and drugs that can modify symptoms.